|
Thank you all for your comments. Even though it is a difficult topic to discuss both emotionally and statistically, from what I've seen in this "conversation", silence by ignorance or fear would be worse.
Human nature being what it is, I think most medical providers are going to be as confused for a while about some of this as we are. I'm holding off from asking my doctors how all of this applies in my situation until more of the dust settles.
I guess the question that still bothers me most is the "my" idea that "the numbers" in regard to the added advantage of herceptin from these clinical trials are based on people who were having chemo for the first time -- not on those who completed it a while back. So, wouldn't it still be important to see what the results were by clinical trial from those who finished chemo some time ago before just putting these people on herceptin alone?
I hope that this forum will continue to provide the opportunity for raising such questions and trying to find the answers to them.
|
Threaded Mode